Self-perceived cognitive decline, neuropsychological functioning, and depressive symptoms in HIV+ Spanish-speakers by Karimian, Ahoo
Pepperdine University 
Pepperdine Digital Commons 
Theses and Dissertations 
2016 
Self-perceived cognitive decline, neuropsychological functioning, 
and depressive symptoms in HIV+ Spanish-speakers 
Ahoo Karimian 
Follow this and additional works at: https://digitalcommons.pepperdine.edu/etd 
Recommended Citation 
Karimian, Ahoo, "Self-perceived cognitive decline, neuropsychological functioning, and depressive 
symptoms in HIV+ Spanish-speakers" (2016). Theses and Dissertations. 703. 
https://digitalcommons.pepperdine.edu/etd/703 
This Dissertation is brought to you for free and open access by Pepperdine Digital Commons. It has been accepted 
for inclusion in Theses and Dissertations by an authorized administrator of Pepperdine Digital Commons. For more 
information, please contact josias.bartram@pepperdine.edu , anna.speth@pepperdine.edu. 
	













































































































































































































Symptoms	in	HIV+	Spanish-Speakers	HIV	infection	and	AIDS	continue	to	be	a	growing	epidemic	in	the	United	States.	The	Centers	 for	 Disease	 Control	 (CDC)	 estimate	 that	 there	 are	 currently	 1.2	 million	 people	living	 with	 HIV	 infection,	 20%	 of	 whom	 are	 unaware	 of	 their	 HIV-positive	 status	 (CDC,	2012).	 Furthermore,	 the	 CDC	 estimates	 that	 approximately	 50,000	 Americans	 become	infected	with	HIV	every	year.	At	least	one-third	of	those	individuals	with	advanced	HIV	will	experience	 some	 neurological	 complications,	 sometimes	 without	 a	 prior	 awareness	 or	diagnosis	of	HIV	infection	(Brew,	2009).	Due	to	the	large	prevalence	and	incidence	of	the	disease,	HIV-associated	neurocognitive	disorders	(HAND)	have	become	more	common	than	other	 traditionally	well-researched	 neurological	 disorders	 such	 as	multiple	 sclerosis	 and	motor	neuron	disease	 (Brew,	2009).	 In	 fact,	HIV-associated	dementia	 (HAD)	has	become	the	most	common	cause	of	dementia	in	individuals	under	the	age	of	50	(Brew,	2009;	Tselis,	2009).	Unlike	other	viral	dementias,	treatment	of	HAD	can	lead	to	significant	improvement	and	 even	 full	 recovery,	 highlighting	 the	 need	 for	 early	 detection	 and	 treatment	 (Brew,	2009).	 Furthermore,	 with	 the	 more	 widespread	 use	 of	 treatments	 such	 as	 combination	antiretroviral	 therapies	 (cART),	health	professionals	are	more	 likely	 to	see	HIV+	patients	presenting	with	milder	forms	of	HAND,	thus	prompting	the	need	for	assessments	that	are	sensitive	 to	 the	more	 subtle	 changes	 associated	with	milder	 cognitive	 declines	 (Valcour,	Paul,	Chiao,	Wendelken,	&	Miller,	2011).	Knowing	which	populations	are	most	at	risk	for	HIV	infection	is	crucial	to	improving	the	odds	of	early	detection.	Research	shows	that	HIV	disproportionately	impacts	the	Latino	population	in	the	United	States.	While	Latino	persons	represent	16%	of	the	U.S.	population,	
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they	accounted	for	20%	of	new	HIV	infections	in	2009	(CDC,	2012).	In	a	report	released	by	the	 Los	 Angeles	 Commission	 on	 HIV,	 Latinos	 were	 found	 to	 comprise	 the	 largest	 group	living	with	HIV/AIDS	 in	Los	Angeles	County,	with	 an	 incidence	of	HIV	 infection	 that	was	more	than	double	that	of	African	Americans	and	Caucasians	(CDC,	2012).	A	growing	clinical	concern	is	that	diagnosis	in	this	group	is	often	significantly	delayed,	thereby	increasing	the	risk	of	developing	HAND	(Levine	et	al.,	2011;	Wohl,	Tejero,	&	Frye,	2009).		In	Los	Angeles	County,	HIV	was	detected	late	in	over	70%	of	Latino	individuals	with	AIDS	(i.e.,	progression	to	AIDS	within	one	year	of	HIV	detection;	Frye,	2004).		In	addition	to	the	increased	awareness	of	heightened	vulnerability	to	HIV	infection	and	HAND	within	a	given	population,	assessments	that	are	accurate,	reliable,	and	valid	are	necessary	 for	 fully	 understanding	 the	 neurocognitive	 impact	 of	 HIV	 on	 each	 individual.	Comprehensive	neuropsychological	assessments	in	the	patients’	preferred	language	are	the	ideal	 method	 of	 evaluation;	 however,	 these	 assessments	 can	 be	 expensive	 and	 at	 times	impractical,	thereby	forcing	clinicians	to	employ	alternative	methods	of	reliably	assessing	for	the	presence	of	cognitive	impairment	in	high-risk	individuals	(Carter,	2001).	Examples	of	alternative	methods	include	using	translated	measures	that	have	not	been	fully	validated	for	 use	 within	 a	 certain	 population	 or	 using	 untrained	 interpreters	 during	 test	administration.	 Regardless	 of	 whether	 preferred	 or	 alternative	 methods	 are	 used,	 it	 is	essential	that	cultural	and	contextual	factors	be	considered	in	order	to	ensure	the	validity	and	usefulness	of	cognitive	assessment	(Manly,	2008).		It	 is	well	known	that	neuropsychological	assessments	are	most	valid	and	accurate	when	administered	in	the	patient’s	primary	language	(Artiola	i	Fortuny	&	Mullaney,	1997;	Cherner	 et	 al.,	 2007).	 Unfortunately,	 there	 is	 evidence	 that	 Latino	 individuals	within	 the	
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U.S.	are	infrequently	given	the	option	to	be	assessed	in	Spanish	(Manly,	2008).	Rather,	they	are	 typically	 assessed	 using	 only	 English	 measures	 and	 instruments,	 even	 when	 their	primary	language	is	Spanish,	thereby	significantly	increasing	the	probability	of	diagnostic	error.	 This	 problematic	 practice	 is	 largely	 due	 to	 the	 relatively	 limited	 availability	 of	Spanish	 language	 neuropsychological	 assessments,	 relevant	 norms,	 and	 appropriately	trained	 bilingual	 neuropsychologists.	 In	 a	 study	 of	 383	 HIV+	 Latino	 individuals	 in	 Los	Angeles	County,	Wohl	et	al.		(2009)	found	that	completion	of	the	study	interview	in	Spanish	was	the	main	factor	associated	with	delayed	HIV	detection	among	this	group.	Of	 particular	 importance	 is	 the	 ability	 to	 reliably	 and	 accurately	 assess	neuropsychological	 impairment	 (NPI)	 in	 an	 efficient	 manner.	 Given	 that	 comprehensive	neuropsychological	assessments	 in	 the	patient’s	primary	 language	are	often	not	available	or	 practical,	 clinicians	 must	 often	 rely	 on	 cognitive	 screeners	 or	 other	 brief	 measures	instead.	 One	 method	 of	 screening	 involves	 the	 use	 of	 self-report	 measures	 of	 everyday	functioning,	as	milder	forms	of	cognitive	impairment	are	often	correlated	with	observable	changes	 in	 functional	ability	(Heaton	et	al.,	2004).	Spanish-language	self-report	measures	of	everyday	functioning	have	been	found	to	be	appropriate	for	use	with	Spanish-speakers	(Rivera-Mindt	 et	 al.,	 2003).	 Such	 measures	 assess	 a	 variety	 of	 domains	 of	 functioning,	including	 cognitive	 functioning,	 social	 functioning,	 and	 occupational	 functioning.	 The	present	study	 focused	on	one	aspect	of	 functional	ability,	self-perceived	cognitive	decline	(i.e.,	cognitive	complaints),	which	has	been	shown	to	be	one	of	the	first	symptoms	reported	in	patients	presenting	with	HIV	infection	(Claypoole	et	al.,	1998).		Though	self-reported	cognitive	decline	may	be	a	promising	method	 for	 identifying	milder	 forms	 of	 HAND,	 there	 are	 important	 limitations	 to	 be	 considered.	 Unqualified	
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reliance	 on	 the	 self-assessment	 of	 cognitive	 decline	 is	 inadvisable,	 as	 such	 reports	 are	highly	susceptible	to	influence	by	various	factors	(e.g.,	mood,	culture,	motivation)	and	may	not	always	accurately	reflect	a	decline	in	functional	ability	(Blackstone	et	al.,	2012;	Branca,	Giordani,	 Lutz,	 &	 Saper,	 1996;	 Moore	 et	 al.,	 1997).	 While	 measures	 of	 self-reported	cognitive	 decline	 alone	 are	 not	 adequate	 predictors	 of	 NPI,	 it	 is	 possible	 that	 using	 this	method	 in	 combination	 with	 measures	 of	 mood	 might	 shed	 light	 on	 an	 individual’s	neuropsychological	profile	without	sacrificing	efficiency.		To	 date,	 relatively	 few	 studies	 have	 focused	 on	 the	 combined	 use	 of	 Spanish-language	 functional	 and	 mood	 measures	 within	 the	 primarily	 Spanish-speaking,	 HIV-positive,	 population.	 Indeed,	 most	 of	 the	 research	 looking	 at	 neuropsychological	 and	functional	 assessment	 in	 HIV	 has	 been	 conducted	 on	 primarily	 English-speaking,	 non-Latino	 populations	 (Rivera-Mindt	 et	 al.,	 2003).	 Hence,	 the	 intent	 of	 this	 study	 was	 to	examine	the	relationship	of	Spanish-language	self-report	measures	of	daily	functioning	to	self-reported	depressive	symptoms	among	Spanish-speaking,	HIV-positive	individuals	with	varying	 levels	 of	 neuropsychological	 impairment.	 For	 the	 present	 study,	 assessment	 of	daily	 functioning	 referred	 only	 to	 self-report	 of	 cognitive	 decline	 (i.e.,	 cognitive	complaints).		In	order	to	provide	more	context	and	background	for	the	study,	brief	reviews	of	the	following	 bodies	 of	 research	 are	 provided:	 (a)	 the	 impact	 of	 HIV	 and	 HAND	 in	 the	predominantly	Spanish-speaking	population,	(b)	current	methods	of	cognitive	assessment	in	 the	Spanish-speaking	population,	 (c)	 the	 relationship	between	self-perceived	cognitive	decline	 and	 NPI,	 and	 (d)	 the	 relationship	 between	 self-perceived	 cognitive	 decline	 and	mood.	Details	about	the	literature	reviewed	are	provided	in	Appendix	A.	
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HIV	and	Latinos	There	has	been	a	major	effort	to	study	the	impact	of	HIV	on	various	ethnicities	and	races	over	the	past	several	decades.	To	date,	much	of	the	research	on	racial	disparities	in	the	 HIV-positive	 population	 has	 highlighted	 the	 impact	 of	 HIV	 on	 the	 African	 American	community	(Gonzalez,	Hendriksen,	Collins,	Durán,	&	Safren,	2009).	While	 it	 is	undeniable	that	 HIV	 affects	 African	 Americans	 most	 disproportionately	 on	 a	 national	 basis	 as	compared	to	all	other	ethnic	groups	(Centers	for	Disease	Control,	2012;	Los	Angeles	County	Department	 of	 Public	 Health,	 2007;	 Los	 Angeles	 County	 Department	 of	 Public	 Health,	2014),	 there	has	been	much	less	research	devoted	to	studying	the	 impact	of	HIV/AIDS	in	the	 Latino	 community	 (Gonzalez	 et	 al.,	 2009).	 Indeed,	 the	 research	 that	 does	 exist	consistently	 shows	 that	Latinos	have	disproportionately	higher	 incidence	and	prevalence	rates	of	infection	than	Caucasians.	In	the	National	Vital	Statistics	Report	on	leading	causes	of	 death	 in	 2002	 published	 by	 the	 CDC,	 HIV/AIDS	 accounted	 for	 10.4%	 and	 6.5%	 of	 all	deaths	 in	Latino	males	and	 females	between	 the	ages	of	35-44,	 respectively,	 a	 rate	more	than	 double	 that	 of	 White	 males	 (4.8%)	 and	 females	 (1.9%)	 in	 the	 same	 age	 group	(Anderson	&	Smith,	2005).	More	recently,	HIV-positive	Latinos	were	additionally	found	to	have	 significantly	worse	health	outcomes	 than	 their	HIV-positive	Caucasian	 counterparts	(Gonzalez	et	al.,	2009).		 While	 several	 notable	 researchers	 (e.g.,	 Ardila,	 Artiola	 i	 Fortuny,	 Cherner,	 Rivera-Mindt,	 etc.)	 have	 made	 great	 strides	 in	 increasing	 awareness	 of	 assessment	 of	 Spanish	speakers	 within	 the	 neuropsychological	 community,	 there	 remain	 relatively	 few	 studies	within	 the	 literature	 that	 focus	 on	 the	 HIV-positive,	 predominantly	 Spanish-speaking	subset	 of	 the	 Latino	 community.	 Indeed,	many	 of	 the	 aforementioned	 researchers	 stress	
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the	 importance	 of	 continued	 neuropsychological	 exploration	 of	 Spanish-speaking	communities.	 The	 need	 for	 increased	 research	 within	 these	 communities	 is	 further	emphasized	when	one	considers	that	the	U.S.	is	home	to	the	world's	fifth-largest	population	of	 Spanish-speakers	 (Ardila,	 2010).	 In	 fact,	 a	 study	 conducted	 on	 600	 Latino	males	 and	females	living	in	Los	Angeles	found	that	75%	of	the	individuals	reported	Spanish	to	be	their	primary	 language	 (Kinsler	et	al.,	2009).	This	 finding	highlights	 the	clinical	 significance	of	studying	and	understanding	the	unique	needs	of	this	specific	subgroup.		Although	 there	 appears	 to	 be	 consensus	 among	 researchers	 as	 to	 the	 need	 for	further	research	on	 the	 impact	of	HIV	 in	 the	Latino	community	 (and	 in	particular	among	predominantly	 Spanish-speaking	 persons),	 there	 also	 appears	 to	 be	 agreement	 that	studying	this	group	is	associated	with	certain	challenges.	With	regard	to	studying	the	HIV+	immigrant	 population,	 Deren,	 Sheldin,	 Decena,	 and	 Mino	 (2005)	 identified	 four	 main	challenges:	 (a)	 the	 need	 for	 multilevel	 theoretical	 frameworks	 in	 order	 to	 address	 the	complexity	 of	 the	 immigrant	 experience;	 (b)	 the	 need	 to	 differentiate	 between	 Latino	subgroups,	 which	 can	 vary	 significantly	 based	 on	 area	 of	 residence	 within	 the	 U.S.;	 (c)	difficulty	recruiting	and	collecting	data	due	to	the	“hidden”	status	of	many	members	(e.g.,	those	 involved	 in	 illegal	 activities	 associated	 with	 drug	 use	 and	 those	 who	 are	undocumented);	 and	 (d)	 ethical	 issues	 inherent	 in	 studying	 a	 multinational/multiethnic	group	 that	 is	 highly	 marginalized	 and	 stigmatized.	 Research	 on	 the	 challenges	 faced	 by	those	who	 immigrate	 to	 the	 U.S.	 from	 various	 Latin	 countries	 and	 cultures	 by	 culturally	competent,	Spanish-speaking	researchers	may	help	to	elucidate	said	complexities	and	help	develop	multilevel	 theoretical	 frameworks	 that	 are	 sensitive	 to	 the	 heterogeneity	 of	 the	Latino	population.	Additionally,	enlisting	the	help	of	local	clinics	and	advocacy	groups	who	
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already	 have	 positive	 relationships	 established	 within	 these	 communities	 may	 help	 to	improve	recruitment	and	data	collection.	Finally,	it	might	be	useful	to	provide	researchers	and	clinicians	who	plan	to	treat	HIV-positive	monolingual	Spanish-speakers	with	advanced	training	that	highlights	some	of	the	ethical	issues	that	are	inherent	to	studying	and	treating	this	vulnerable	population.		Parallel	 to	 the	 challenges	 faced	 by	 researchers	 in	 accessing	 and	 studying	 the	predominantly	Spanish-speaking	population	are	the	challenges	 faced	by	these	 individuals	in	 receiving	 adequate	 healthcare.	 Numerous	 studies	 have	 shown	 that	 individuals	 who	speak	Spanish	as	 their	primary	 language	 face	various	obstacles	when	attempting	 to	 seek	services.	For	instance,	in	a	study	investigating	the	reasons	for	the	disproportionate	impact	of	HIV	and	AIDS	in	the	Spanish-speaking	community,	Gonzalez	et	al.	(2009)	found	that	cost	of	 services,	 lack	 of	 access	 to	 resources,	 and	 difficulty	 communicating	 with	 healthcare	professionals	were	among	the	most	significant	barriers	to	care.	In	a	study	focusing	on	the	relationships	 among	 acculturation,	 utilization	 of	 HIV	 services,	 and	 access	 to	 care	 in	Spanish-speaking	 individuals	 at-risk	 for	 contracting	 HIV	 through	 sexual	 intercourse	 or	injection	 drug	 use,	 Kinsler	 et	 al.	 (2009)	 found	 that	 when	 compared	 to	 their	 English-speaking	counterparts,	Spanish-speakers	with	 lower	 levels	of	acculturation	were	 less	 like	to	engage	in	HIV	testing,	more	likely	to	test	positive	for	HIV	when	they	did	get	tested,	and	less	likely	to	have	access	to	healthcare	services.	Additionally,	a	phenomenological	study	of	undocumented,	 HIV-positive,	 Spanish-speaking	 immigrants	 by	 Dang,	 Giordano,	 and	 Kim	(2012)	found	that	there	were	two	major	barriers	to	care	and	treatment	retention:	dealing	with	rejection	from	family	and	friends	due	to	stigma,	as	well	as	experienced	and	perceived	structural	barriers	of	accessing	care	as	an	undocumented	immigrant.	Since	the	study	of	this	
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population	 is	 predicated	 on	 individuals	 accessing	 services,	 if	 services	 are	 not	 accessed,	these	individuals	continue	to	be	overlooked	in	the	literature.	Developing	and	implementing	culturally	 sensitive	 intervention	 programs	 that	 target	 this	 population	 and	 address	 these	barriers	 is	 necessary	 not	 only	 to	 improve	 access	 to	 care,	 but	 also	 to	 promote	 further	research.	
Assessment	with	Spanish	Speakers	Spanish	is	considered	to	be	the	second	most	commonly	spoken	language	in	the	U.S.,	where	 the	world’s	 fifth	 largest	 population	 of	 Spanish-speakers	 resides	 (Ardila,	Ostrosky-Solis,	 Rosselli,	 &	 Gomez,	 2000;	 Cherner	 et	 al.,	 2007).	 According	 to	 the	 2010	 U.S.	 Census	Report,	 a	 little	over	37	million	 residents	5	years	 and	older	 reported	 speaking	Spanish	at	home,	a	population	that	has	more	than	doubled	in	the	past	two	decades.	Of	that	37	million,	approximately	 16	 million	 endorsed	 speaking	 English	 less	 than	 “very	 well,”	 a	 fact	 that	underscores	the	need	for	culturally	and	linguistically	appropriate	services,	particularly	in	a	domain	as	crucial	as	healthcare	(U.S.	Census	Bureau,	2012).	The	 importance	of	providing	adequate	healthcare	resources	to	such	a	large	portion	of	the	population	cannot	be	denied,	and	 yet,	 as	 the	 population	 of	 Spanish-speakers	 within	 the	 U.S.	 continues	 to	 grow,	 the	neuropsychological	 services	 that	 cater	 to	 Spanish-speakers	 remain	 relatively	 limited	(Ardila	et	al.,	2000;	Cherner	et	al.,	2007).			In	 the	 literature,	 the	 two	 most	 commonly	 cited	 challenges	 to	 providing	neuropsychological	 services	 to	 Spanish-speakers	 include	 limited	 availability	 of	 validated	Spanish	 language	measures	 and	 sparse	 normative	 data,	 both	 of	 which	 contribute	 to	 the	probability	of	misdiagnosis	(Ardila	et	al.,	2000;	Artiola	i	Fortuny	&	Mullaney,	1997;	Cherner	et	al.,	2007).		In	fact,	neuropsychological	performance	of	ethnic	minorities	has	been	reliably	
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shown	to	be	worse	than	that	of	their	Caucasian	counterparts	across	several	studies	on	both	verbal	and	nonverbal	tasks	(Brickman,	Cabo,	&	Manly,	2006).	This	is	thought	to	be	mostly	due	to	 issues	 in	validity	and	the	availability	of	appropriate	measures	and	normative	data	(Artiola	 i	 Fortuny	 &	 Mullaney,	 1997).	 Furthermore,	 sociocultural	 influences	 such	 as	 the	systemic	 bias	 that	 many	 ethnic	 minorities	 face	 significantly	 impacts	 construct	 validity.	Indeed,	there	is	evidence	that	the	meaning	and	relevance	of	a	test	can	differ	between	ethnic	groups	so	much	so	that	the	cognitive	construct	a	specific	test	was	designed	to	measure	is	no	longer	valid	(e.g.,	confrontation	naming	in	a	population	that	has	limited	exposure	to	the	stimuli	being	presented;	Brickman	et	al.,	2006;	Groth-Marnat,	2009).	Such	studies	illustrate	the	 need	 for	 development	 of	 culturally	 and	 linguistically	 appropriate	 measures	 when	assessing	individuals	from	diverse	cultural	backgrounds.	For	 over	 a	 decade,	 researchers	 and	 clinicians	 have	 been	 referencing	 the	 need	 for	more	widespread	availability	of	validated	Spanish	 language	assessments.	Historically,	 the	biggest	 challenge	 with	 Spanish	 language	 measures	 had	 to	 do	 with	 quality	 of	 the	translations.	 A	 review	by	Artiola	 i	 Fortuny	 and	Mullaney	 (1997)	 found	 that	many	 of	 the	neuropsychological	measures	that	had	been	translated	into	Spanish	at	the	time	contained	syntactical,	lexical,	and	grammatical	errors	that	even	native	Spanish	speakers	with	limited	education	 could	 detect.	 The	 need	 for	 appropriately	 worded	 assessment	 measures	 is	 of	particular	importance	in	the	early	detection	of	HIV	deficits,	given	that	the	earlier	stages	of	the	disease	process	are	more	likely	to	induce	subtle	changes	and	declines	that	may	not	be	otherwise	 detected	 due	 to	 linguistic	 and	 cultural	 barriers.	 Although	 there	 have	 not	 been	any	comparable	studies	since	then	that	reviewed	the	quality	of	available	Spanish	language	measures,	it	appears	that	researchers	have	made	concerted	efforts	to	address	the	issue	of	
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quality	by	 suggesting	guidelines	 for	 Spanish	 language	 test	development,	 reevaluating	 the	standards	 by	 which	 neuropsychologists	 conduct	 assessments	 within	 linguistically	 and	ethnically	diverse	populations,	and	by	continuing	to	propel	the	discussion	forward	within	the	scientific	community	(Ardila	et	al.,	2000;	Artiola	i	Fortuny	&	Mullaney	1997;	Cherner	et	al.,	2007;	Horton,	2008;	Manly,	2008;	Romero	et	al.,	2009).		In	line	with	these	efforts,	there	have	been	at	least	two	major	instrument	validation	studies	 in	 the	 past	 decade	 that	 have	 focused	 on	 the	 development	 of	 culturally	 and	linguistically	sensitive	Spanish-language	neuropsychological	batteries	for	use	with	the	HIV-positive	population.	The	first	was	a	study	conducted	by	Wilkie	et	al.	(2004)	that	focused	on	the	 development	 of	 the	 HIV/University	 of	 Miami	 Annotated	 Neuropsychological	 test	battery	in	Spanish	(HUMANS).	The	second	study	focused	on	the	use	of	Spanish	translated	functional	measures	for	detecting	functional	 impairment	in	everyday	functioning	(Rivera-Mindt	et	al.,	2003).	However,	despite	these	meaningful	efforts,	neuropsychological	testing	among	culturally	and	linguistically	diverse	populations	remains	an	area	of	weakness	within	the	field	(Manly,	2008).		Equally	as	important	as	the	need	for	validated	Spanish	assessments,	there	is	a	dire	need	for	demographically	adjusted	normative	data	with	which	to	compare	an	individual’s	test	 results	 (Antinori	 et	 al.,	 2007).	 Many	 of	 the	 tests	 that	 are	 currently	 used	 as	 gold	standards	 in	 the	 assessment	 of	 Spanish-speakers	 lack	 normative	 data	 for	 specific	 Latino	groups	 with	 limited	 or	 very	 advanced	 educational	 backgrounds	 (Candelaria	 &	 Llorente,	2009).	 This	 is	 of	 grave	 importance,	 as	 studies	 have	 shown	 that	 a	 lack	 of	 appropriate	normative	data	can	significantly	influence	the	interpretation	of	test	results.	For	instance,	a	study	 by	 Cherner	 and	 colleagues	 (2007)	 at	 the	 HIV	 Neurobehavioral	 Research	 Center	
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focusing	 on	 the	 need	 for	 demographically	 adjusted	 norms	 for	 monolingual	 Spanish	speakers	 along	 the	 U.S.-Mexico	 border	 found	 that	 when	 standard	 norms	 were	 used	 to	interpret	performance	on	a	figure	learning	test,	31%	of	individuals	tested	were	classified	as	cognitively	impaired.	However,	when	norms	that	were	designed	for	Spanish-speakers	were	used,	 the	base	 rate	of	 impairment	 in	 the	 sample	dropped	 to	half	 of	 the	original	 estimate	(15%).	 Additionally,	 the	 authors	 demonstrated	 that	 among	 those	 individuals	 with	 more	limited	 education	 (1-5	 years),	 the	 use	 of	 education-adjusted	 norms	 resulted	 in	 a	 50%	decrease	in	the	classification	of	impairment	(from	40%	to	20%;	Cherner	et	al.,	2007).		
Self-Perceived	Cognitive	Decline	and	Objective	Cognitive	Functioning	According	 to	 the	 most	 current	 research	 nosology	 published	 in	 the	 journal	 of	 the	American	Academy	of	Neurology	(AAN),	HAND	can	be	classified	into	three	categories:	(a)	asymptomatic	 neurocognitive	 impairment	 (ANI),	 (b)	 HIV-associated	mild-neurocognitive	impairment	 (MND),	 and	 (c)	 HIV-associated	 dementia	 (HAD).	 ANI	 is	 assigned	 when	 an	individual’s	 cognitive	 performance	 is	 at	 least	 1	 standard	 deviation	 (SD)	 below	demographically	adjusted	normative	scores	in	at	least	two	ability	domains	(e.g.,	processing	speed	 and	 attention/concentration).	 In	 addition,	 there	must	 be	 an	 absence	 of	 functional	impairment,	 and	 the	 cognitive	deficits	 cannot	be	better	accounted	 for	by	 the	presence	of	delirium,	 dementia,	 or	 a	 preexisting	 cause.	 MND,	 on	 the	 other	 hand,	 is	 defined	 by	 an	acquired	mild-to-moderate	decline	in	cognitive	impairment	in	at	least	two	ability	domains	that	falls	1	SD	below	the	mean,	but	is	accompanied	by	functional	impairment	that,	at	least	mildly,	 interferes	 with	 activities	 of	 daily	 living	 (ADLs).	 Similar	 to	 ANI,	 the	 impairment	present	in	MND	cannot	be	better	accounted	for	by	a	diagnosis	of	delirium,	dementia,	or	any	comorbid	conditions	that	can	fully	explain	the	impairment.	The	most	severe	category,	HAD,	
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is	classified	by	a	moderate-to-severe	decline	in	cognitive	functioning	in	at	least	two	ability	domains	 that	 falls	 2	 SD	 below	 the	 normative	 mean	 and	 causes	 marked	 interference	 in	functioning.	Like	ANI	and	MND,	the	impairment	cannot	be	better	accounted	for	by	delirium	and	there	must	be	no	evidence	of	another,	preexisting	cause	for	dementia	(Antinori	et	al.,	2007).		In	 terms	 of	 cognitive	 functioning,	 at	 least	 five	 of	 the	 following	 areas	 must	 be	assessed	before	 a	diagnosis	 of	HAND	can	be	 given:	 executive	 function,	 episodic	memory,	processing	 speed,	 motor	 functioning,	 attention/working	 memory,	 language,	 and	sensoriperception.	A	minimum	of	 two	abnormal	 test	 results	 is	 required	 to	 assign	overall	neurocognitive	 impairment,	with	 at	 least	 one	 cognitive	deficit	 present	 in	 a	 given	domain	(e.g.,	 impairment	 in	 sensoriperception	and	motor	 functioning	alone	would	not	warrant	 a	diagnosis	 of	 HAND).	 HIV-associated	 cognitive	 impairments	 are	most	 commonly	 found	 in	the	domains	of	attention/working	memory,	information	processing,	learning	and	memory,	and	 executive	 function,	 with	memory	 and	motor	 impairment	most	 prevalent	 during	 the	early	 stages	 of	 infection,	 (i.e.,	 when	 patients	 are	 still	 in	 the	 asymptomatic	 phase	 of	 the	disease;	 Bornstein	 et	 al.,	 1993).	 It	 is	 important	 to	 note	 that	 fluctuations	 in	 impairment,	particularly	cognitive	impairment,	are	often	seen	throughout	the	course	of	HAND	(Woods,	Moore,	Weber,	&	Grant,	2009).			In	addition	to	cognitive	decline,	 the	presence	of	 functional	 impairment	 is	a	critical	criterion	in	the	diagnosis	of	HAND	(Woods	et	al.,	2009).		Functional	impairment	refers	to	an	inability	 to	 perform	 everyday	 activities,	 often	 referred	 to	 as	 ADLs,	 and	 instrumental	activities	of	daily	living	(IADLs).	ADLs	include	basic	functions	such	as	bathing,	dressing,	and	feeding	oneself,	while	IADLs	involve	more	cognitively	demanding	tasks,	such	as	making	and	
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keeping	appointments,	preparing	meals,	shopping	for	groceries,	etc.	Functional	ability	can	be	 assessed	 through	 subjective	 self-report	 measures,	 a	 reliable	 third	 party	 such	 as	 a	partner	 or	 caretaker,	 and/or	 objective	 measures	 that	 assess	 the	 individual’s	 ability	 to	successfully	 perform	 various	 cognitively	 related	 IADLs,	 such	 as	management	 of	 finances	and	 medications	 or	 driving	 ability	 (Antinori	 et	 al.,	 2007).	 At	 present,	 there	 is	 no	 gold	standard	 for	 clinical	 assessment	 of	 everyday	 functioning	 (Heaton	 et	 al.,	 2004;	Morgan	&	Heaton,	 2009).	 While	 there	 is	 evidence	 to	 suggest	 that	 a	 multimodal	 approach	 (e.g.,	utilization	 of	 both	 self-report	 and	 performance	 based	 measures)	 is	 better	 at	 detecting	symptomatic	HAND	 than	either	objective	or	 self-report	methods	alone	 (Blackstone	et	 al.,	2012),	clinical	assessment	of	everyday	functioning	more	commonly	relies	on	patient	self-report	due	to	factors	such	as	limited	time	and	resources	(Antinori	et	al.,	2007;	Woods	et	al.	2009).	 Furthermore,	 self-report	 measures	 offer	 certain	 advantages,	 such	 as	 having	 high	face	validity,	being	low-cost,	and	placing	minimal	burden	on	the	patient	(Blackstone	et	al.,	2012).	As	previously	mentioned,	self-report	of	cognitive	status	is	one	method	of	assessing	a	patient’s	everyday	 functioning	that	 is	widely	used	due	to	 the	cognitive	nature	of	many	of	the	tasks	constituting	ADL’s	and	IADL’s,	such	as	driving,	managing	one’s	medications,	and	maintaining	adequate	hygiene	(Heaton	et	al.,	2004;	Thames	et	al.,	2011).	According	 to	 the	 AAN,	 functional	 impairment	 is	 divided	 into	 two	 categories:	mild	and	major.	Mild	functional	impairment	requires	at	least	two	of	the	following:	(a)	reports	of	need	 for	 increased	 assistance	with	 at	 least	 two	 IADLs;	 (b)	 if	 employed,	 loss	 of	 ability	 to	perform	aspects	of	one’s	 job	 that	cannot	be	attributed	 to	medical	 sources	 (e.g.,	being	 too	sick	 to	 get	 out	 of	 bed);	 (c)	 difficulty	 meeting	 demands	 due	 to	 decreased	 efficiency	 and	accuracy	or	increased	effort	in	performing	tasks	at	work	or	at	home;	(d)	lack	of	significant	
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depressive	symptoms	(e.g.,	scores	less	than	17	on	the	Beck	Depression	Inventory);	and	(e)	performances	 of	 greater	 than	 1	 SD	 below	 the	 normative	 mean	 on	 performance-based,	standardized	 functional	 tests	 (Antinori	 et	 al.,	 2007).	Major	 functional	 impairment,	on	 the	other	hand,	requires	that	two	or	more	of	the	following	be	present:	(a)	inability	to	maintain	employment	 for	 reasons	 that	 are	 not	 attributable	 to	 systemic	 illness	 or	 other	 factors	unrelated	 to	 cognitive	 impairment;	 (b)	 dependence	 or	 increased	 need	 of	 substantially	greater	assistance	with	more	 than	 two	 IADLs;	 (c)	self	and	 informant	report	of	 significant	difficulty	with	four	or	more	aspects	of	cognition	(if	the	individual	scores	17	or	greater	on	the	 BDI,	 then	 self-reported	 cognitive	 decline	 alone	 is	 insufficient	 and	 requires	corroboration	from	a	reliable	third	party);	and	(d)	scores	that	are	2	or	more	SD	below	the	normative	mean	on	performance-based,	standardized	functional	tests.	In	both	cases,	these	declines	must	not	 be	more	 readily	 attributable	 to	medical	 or	 other	 comorbid	 conditions,	such	 as	 the	 effects	 of	 medication,	 opportunistic	 infection,	 or	 developmental	 or	 acquired	conditions	 unrelated	 to	 HIV	 (Antinori	 et	 al.,	 2007).	 Because	 assessment	 of	 HAND	 is	predicated	 on	 declines	 in	 everyday	 functioning,	 and	 because	 fluctuations	 in	 cognitive	impairment	are	often	seen	throughout	the	course	of	HAND,	it	is	imperative	that	functional	status	 be	 accurately	 assessed	 and	 monitored	 in	 HIV-positive	 individuals	 (Woods	 et	 al.,	2009).	As	with	any	assessment,	evaluation	of	functional	abilities	must	be	carried	out	within	the	 context	 of	 culture.	 Sociocultural	 factors	 can	 significantly	 impact	 the	 presentation	 of	functional	abilities.	For	instance,	IADLs	often	reflect	a	common	way	of	living	that	can	vary	considerably	 across	different	 cultures,	 family	 systems,	 and	 socioeconomic	 circumstances.	As	such,	it	is	recommended	that	functional	measures	be	adapted	for	cross-cultural	use	and	
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that	clinicians	carefully	screen	tests	and	questionnaires	assessing	IADLs	to	ensure	that	they	are	 relevant	 to	 the	 individual’s	 cultural	 context	 (Antinori	 et	 al.,	 2007).	 In	 terms	 of	functional	ability	as	measured	by	reports	of	cognitive	decline,	 it	 is	 important	to	note	that	HIV-associated	 changes	 in	 cognitive	 decline	 may	 go	 unnoticed	 in	 cultures	 or	 individual	living	situations	that	pose	relatively	few	demands	for	complex	cognitive	abilities	(Antinori	et	al.,	2007).	Thus,	clinicians	must	also	account	for	the	individual’s	current	living	situations	in	addition	to	factors	such	as	culture,	age,	and	education.	As	 with	 the	 relationship	 between	 basic	 cognitive	 functioning	 (as	 measured	 by	neuropsychological	tests)	and	everyday	functioning,	the	relationship	between	self-reported	functional	 impairment	 and	 neuropsychological	 performance	 is	 not	 clearly	 understood	(Blackstone	et	al.,	2012;	Woods	et	al.,	2009;	Valcour	et	al.,	2011).	This	is	due	in	part	to	the	susceptibility	 of	 self-reports	 to	 the	 influence	 of	 numerous	 psychiatric	 and	 psychosocial	factors,	 including	 mood,	 motivation,	 secondary	 gain,	 etc.	 (Heaton	 et	 al.,	 2004).	 To	 date,	several	studies	have	attempted	to	explore	the	relationship	between	self-reported	cognitive	decline	and	neuropsychological	performance	with	mixed	results.			For	 example,	 there	 are	 several	 studies	 whose	 results	 support	 the	 use	 of	 self-perceived	 cognitive	 status	 to	 predict	 NPI	 in	 the	 HIV-positive	 population.	 An	 instrument	validation	 study	 by	 Knippels,	 Goodkin,	 Weiss,	 Wilkie,	 and	 Antoni	 (2002)	 using	 a	 Dutch	translated	version	of	 the	MOS-HIV,	a	 commonly	used	 four-item	cognitive	status	 subscale,	showed	 a	 significant	 association	 between	 self-reported	 cognitive	 impairments	 and	decreased	overall	neuropsychological	functioning.	Another	study	by	Bornstein	et	al.	(1993)	found	a	significant	correlation	between	the	subject’s	scores	on	the	Sickness	Impact	Profile	(SIP),	 another	 commonly	 used	 brief	 functional	 screener	 assessing	 cognitive	 functioning,	
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and	neuropsychological	performance,	even	after	controlling	for	age,	education,	depression,	and	weekly	 alcohol	 consumption.	 A	 study	 by	 Derouesnè	 et	 al.	 (1993)	 found	 a	weak	 but	significant	correlation	between	the	Cognitive	Difficulties	Scale	(CDS)	and	performance	on	a	short	neuropsychological	battery.	Perhaps	most	relevant,	preliminary	findings	from	a	pilot	study	 to	 determine	 the	 validity	 of	 using	 Spanish	 language	 functional	 measures	 to	determine	neuropsychological	impairment	in	a	small	sample	of	Spanish	speaking	adults	(N	=	 16)	 showed	 that	 self-reported	 functional	 impairment	was	 significantly	 correlated	with	overall	 NPI	 (Rivera-Mindt	 et	 al.,	 2003).	 In	 this	 pilot	 study,	 NPI	 was	 measured	 with	 a	comprehensive	 neuropsychological	 Spanish	 language	 battery	 that	 was	 previously	developed	for	a	study	exploring	neuropsychological	performance	in	Spanish	speakers.	The	results	 of	 these	 studies	 support	 the	 use	 of	 brief,	 self-report	 functional	 screeners	 in	assessing	for	changes	in	cognitive	abilities	in	the	early	stages	of	HIV-infection.	On	 the	other	hand,	 several	 studies	have	 failed	 to	 find	a	 relationship	between	self-reported	 functional	 impairment	 and	 neuropsychological	 functioning.	 A	 study	 aimed	 at	determining	 whether	 self-reported	 measures	 of	 functional	 decline	 were	 as	 effective	 in	characterizing	 HAND	 as	 performance-based	 measures	 found	 unemployment	 and	immunosuppression	 to	 be	more	 highly	 correlated	with	 objective	measures	 of	 functional	impairment,	 while	 self-reported	 functional	 impairment	was	more	 highly	 correlated	with	depressive	 symptoms	 (Blackstone	 et	 al.,	 2012).	Another	 study	 exploring	 the	 relationship	between	 self-reported	 cognitive,	 motor,	 and	 affective	 complaints	 and	 objective	neuropsychological	 performance	 failed	 to	 find	 a	 significant	 relationship	 between	objectively	measured	cognitive	functioning	and	cognitive	complaints	(Moore	et	al.,	1997).	However,	Moore	 and	 coauthors	 did	 find	 a	 significant	 relationship	 between	 self-reported	
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cognitive	difficulties	and	depressive	symptoms.	A	study	by	Sadek,	Vigil,	Grant,	and	Heaton	(2007)	 found	 depressive	 symptoms	 to	 be	 predictive	 of	 greater	 declines	 in	 IADLs	 and	cognitive	 complaints	 in	 a	 sample	 of	 362	 HIV+	 and	 HIV-	 individuals	 with	 and	 without	methamphetamine	 dependence,	 while	 neuropsychological	 impairment	 was	 found	 to	 be	more	predictive	of	cognitive	complaints	than	declines	in	IADL.		It	 is	 clear	 that	 controversy	 remains	 over	 the	 degree	 to	 which	 self-perceived	cognitive	 decline	 is	 indicative	 of	 neuropsychological	 impairment	 in	 HIV-positive	individuals.	 Some	 studies	 have	 found	 a	 significant	 relationship	 between	 self-perceived	cognitive	 decline	 and	 neuropsychological	 impairment	 while	 others	 have	 not,	 with	 a	number	of	studies	identifying	a	relationship	between	self-perceived	cognitive	decline	and	the	 presence	 of	 mood	 symptoms	 (e.g.,	 Bassel,	 Rourke,	 Halman,	 &	 Smith,	 2002).	 Further	research	 into	 the	 relationship	 between	 self-perceived	 cognitive	 decline	 and	 objective	cognitive	 performance	 is	 warranted,	 as	 it	 may	 improve	 early	 detection	 and	 promote	beneficial	treatment	for	Spanish-speaking	individuals	with	HIV.	Moreover,	it	may	be	useful	to	 further	explore	 the	relationship	between	self-perceived	cognitive	decline	and	mood	as	they	relate	to	neuropsychological	performance.			
Mood,	Cognitive	Complaints,	and	Objective	Cognitive	Functioning	Much	 like	 literature	 on	 the	 relationship	 between	 subjective	 complaints	 and	neuropsychological	 impairment,	 the	 literature	 on	 the	 relationship	 between	 depressive	symptoms	and	neuropsychological	impairment	among	HIV+	individuals	has	been	variable.	A	 landmark	 study	 conducted	 by	 Grant	 and	 colleagues	 (1993)	 addressed	 the	 early	controversy	 over	 whether	 or	 not	 depression	 accounted	 for	 the	 neuropsychological	impairment	 present	 in	 HIV.	 This	 study	 aimed	 to	 explore	 the	 relationship	 between	
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depressed	 mood	 and	 cognitive	 impairment	 in	 a	 sample	 of	 gay	 males	 (N	=	 139),	 101	 of	whom	 were	 HIV+.	 Results	 showed	 that	 while	 HIV+	 participants	 in	 later	 stages	 of	 the	disease	were	more	 likely	 to	 present	 with	 both	 depressed	mood	 and	 neuropsychological	impairment,	 there	 were	 no	 significant	 relationships	 between	 depression	 and	neuropsychological	 impairment	 observed.	 Similarly,	 a	 study	 by	 Claypoole	 et	 al.	 (1998)	revealed	that	while	memory	complaints	were	highly	correlated	with	depression,	there	was	no	 greater	 improvement	 in	 neuropsychological	 functioning	 despite	 improvement	 in	depressive	 symptoms.	 The	 results	 of	 these	 early	 studies	made	 it	 clear	 that	 the	 cognitive	declines	seen	in	HIV	cannot	merely	be	attributed	to	the	effects	of	depression.		Thus,	while	 there	 is	 evidence	 to	 support	 the	 notion	 that	HIV-associated	 cognitive	decline	is	not	solely	accounted	for	by	depressive	symptoms,	there	are	contrasting	studies	that	suggest	the	relationship	between	mood	and	objective	cognitive	decline	is	still	unclear.	One	such	study	conducted	by	Vásquez-Justo,	Rodriguez	Alvares,	and	Ferraces	Otero	(2003)	showed	 that	 although	 HIV-positive	 individuals	 who	 endorsed	 depressive	 symptoms	performed	 more	 poorly	 on	 measures	 of	 attention,	 verbal	 and	 visual	 memory,	 visual-constructive	abilities,	manual	skills	and	motor	speed,	motor-perceptive	speed,	and	frontal	functions,	 other	 studies	 using	 the	 same	 instruments	 did	 not	 find	 an	 effect	 of	 mood	 on	neuropsychological	performance	(Bix	et	al.,	1995;	Grant	et	al.,	1993).	The	authors	went	on	to	 point	 out	 that	 while	 it	 is	 now	 widely	 accepted	 that	 HIV	 has	 a	 measureable	 negative	impact	 on	 the	 central	 nervous	 system,	 these	 results	 suggest	 that	 neuropsychological	impairment	 in	 individuals	with	HIV	 is	 likely	due	 to	 a	 combination	of	 factors	 that	may	or	may	not	include	depressive	symptoms	(Vázquez-Justo	et	al.,	2003).			
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A	 major	 contributor	 to	 this	 lack	 of	 clarity	 within	 the	 literature	 is	 the	 fact	 that	subjective	 self-report	 of	 daily	 functioning	 has	 been	 shown	 to	 be	 highly	 correlated	 with	depressive	 symptoms,	 especially	with	 respect	 to	 reports	of	 cognitive	decline	 (Antinori	 et	al.,	 2007;	 Carter,	 Rourke,	 Murji,	 Shore,	 &	 Rourke,	 2003;	 Heaton	 et	 al.,	 2004;	 Rourke,	Halman,	&	Bassel,	1999;	Thames	et	al.,	2011).	However,	 there	 is	evidence	to	suggest	 that	while	 depressed	 mood	 and	 medical	 symptoms	 can	 influence	 self-reported	 cognitive	difficulties,	 cognitive	 complaints	 are	 independently	 associated	 with	 poorer	neuropsychological	 performance	 in	 HIV-positive	 individuals;	 thus,	 the	 presence	 of	depression	or	medical	symptoms	should	not	dismiss	the	usefulness	of	cognitive	complaints	in	 indicating	 neuropsychological	 impairment	 within	 this	 population	 (Carter	 et	 al.,	 2003;	Carter,	2001).	
Problem	Statement	Research	 shows	 that	HIV	disproportionately	 impacts	 the	Latino	population.	While	Latino	 individuals	 represent	16%	of	 the	U.S.	 population,	 they	 accounted	 for	20%	of	 new	HIV	 infections	 in	 2009	 (CDC,	 2012).	 A	 growing	 clinical	 concern	 is	 that	 diagnosis	 in	 this	group	 is	 often	 delayed,	 thereby	 increasing	 the	 risk	 of	 developing	 HAND	 (Levine	 et	 al.,	2011).	Comprehensive	neuropsychological	assessments	are	the	ideal	method	of	evaluating	neurocognitive	 deficits;	 however,	 these	 assessments	 can	 be	 expensive	 and	 at	 times	impractical,	thus	forcing	clinicians	to	employ	alternative	methods	of	reliably	assessing	the	existence	 of	 cognitive	 impairment	 in	 high-risk	 individuals	 (Carter,	 2001).	 Unfortunately,	there	is	a	lack	of	appropriate	Spanish	language	measures	and	norms	available	for	primarily	Spanish-speaking	 individuals,	 resulting	 in	 increased	probability	 of	 diagnostic	 error	when	these	 individuals	 are	 assessed.	 It	 has	 been	 suggested	 that	 using	 self-report	measures	 of	
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functional	 ability	may	 be	 an	 efficient	method	 for	 indicating	whether	 an	 individual	 needs	further	 neuropsychological	 assessment.	 Self-report	 measures	 of	 functioning	 are	 useful	because	 they	capture	 cognitive	 complaints	and	other	declines	 in	 functioning	experienced	by	HIV+	individuals.	However,	the	relationship	of	self-reported	functioning	to	NPI	may	be	moderated	 by	 the	 presence	 of	 depressive	 symptoms.	 A	 particular	 concern	 is	 whether	depressive	symptoms	may	 lead	 individuals	to	over-report	cognitive	decline	and	cognitive	deficits.	 Indeed,	as	per	the	AAN	guidelines,	self-reported	declines	 in	cognitive	 functioning	alone	are	not	sufficient	to	indicate	the	presence	of	HAND	when	an	individual	is	endorsing	significant	 depressive	 symptoms	 (i.e.,	 scores	 17	 or	 higher	 on	 the	 BDI).	 The	 impact	 of	subclinical	depressive	 symptoms	on	 the	 relationship	of	 self-reported	 cognitive	decline	 to	NPI	also	needs	research	attention.	Before	that	can	be	explored,	however,	more	research	is	needed	 to	 better	 understand	 how	depressive	 symptoms	 relate	 to	 self-reported	 cognitive	decline	in	this	population.		The	 aim	 of	 this	 study	 was	 twofold.	 First,	 the	 relationship	 between	 self-reported	cognitive	complaints	and	depressive	symptoms	was	examined.	It	has	been	shown	that	the	presence	 of	 mood	 symptoms	 is	 highly	 correlated	 with	 over-reporting	 self-perceived	cognitive	decline	(see	Heaton	et	al.,	2004;	Thames	et	al.,	2011;	Woods	et	al.,	2009).	In	the	present	 sample,	 it	 was	 predicted	 that	 greater	 self-reported	 cognitive	 decline	 would	 be	associated	 with	 greater	 depressive	 symptoms.	 Moreover,	 it	 was	 expected	 that	 this	relationship	would	hold	 regardless	 of	HAND	status.	The	 second	aim	of	 this	 study	was	 to	explore	how	neuropsychological	functioning	and	cognitive	complaints	impacted	depressive	symptoms.	 More	 specifically,	 the	 study	 investigated	 the	 depressive	 symptoms	 present	among	individuals	who	met	criteria	for	a	diagnosis	of	HAND	and	those	who	did	not	in	an	
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effort	to	better	understand	the	relationship	between	cognitive	complaints	and	mood.	Each	group,	 HAND	 versus	 no-HAND,	 was	 further	 divided	 into	 two	 subcategories:	 those	 who	endorsed	self-perceived	cognitive	declines	and	 those	who	did	not.	Depressive	symptoms,	as	measured	on	the	Beck	Depression	Inventory	(Beck,	Ward,	Mendelson,	Mock,	&	Erbaugh,	1961),	were	compared	between	the	groups	to	see	what	differences	existed.	The	main	effect	of	 HAND,	 as	 well	 as	 the	 interaction	 of	 HAND	 and	 self-reported	 cognitive	 decline,	 on	depressive	symptoms	was	examined	but	no	a	priori	hypotheses	were	generated	due	mixed	findings	within	the	literature	(Antinori	et	al.,	2007;	Carter	et	al.,	2003;	Heaton	et	al.,	2004;	Rourke	et	al.,	1999;	Thames	et	al.,	2011;	Vázquez-Justo	et	al.,	2003).	Given	the	potential	 influence	of	cultural	factors	on	self-report	(see	Brickman	et	al.,	2006;	 Groth-Marnat,	 2009),	 an	 acculturation	 scale	 was	 used	 to	 explore	 whether	acculturation	 impacted	 the	 relationship	 between	 cognitive	 complaints	 and	neuropsychological	functioning	on	depressive	symptom	reporting.	
Methods	The	present	study	was	an	archival	study	based	on	data	drawn	from	an	original	study	conducted	at	Cedars	Sinai	Medical	Center	in	Los	Angeles,	CA.	The	parent	study	was	entitled:	“HIV	 Neurocognitive	 Disorders	 among	 Primary	 Spanish-Speakers	 in	 Los	 Angeles.”	 The	principal	investigator	was	Dr.	Enrique	Lopez	and	he	gave	permission	for	the	present	author	to	have	access	to	a	subset	of	de-identified	data.	The	original	study	was	supported	by	a	grant	from	the	National	 Institute	of	Mental	Health	 (K23	MH087290).	The	archival	data	used	 in	the	present	investigation	was	only	accessed	after	IRB	approval	was	received	at	Pepperdine	University	Graduate	School	of	Education	and	Psychology.	
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Participants		The	present	 study	 consisted	of	100	predominantly	Spanish-speaking,	HIV-positive	individuals	 (80	 males,	 11	 females,	 9	 transgender)	 who	 consented	 to	 participate	 in	 the	parent	study	at	Cedars	Sinai	Medical	Center.	Participants	ranged	in	age	from	28-62,	with	a	mean	of	44.95	years	(SD	=	7.63).	Their	years	of	education	ranged	from	1	to	20,	with	a	mean	of	10.24	(SD	=	3.36).	In	regard	to	health	variables,	their	mean	CD4	cell	count	at	the	time	of	assessment	 was	 479.93	 (SD	 =	 224.22),	 with	 65.1%	 of	 the	 sample	 possessing	 an	undetectable	 viral	 load.	 The	 self-reported	 geographical	 origin	 for	 this	 sample	 was	 as	follows:	Mexico,	71%;	Central	America,	23%;	and	South	America,	6%.		The	 parent	 study	 inclusionary	 criteria	 for	 subjects	 were	 as	 follows:	 1)	predominantly	 Spanish	 speaking	 HIV	 positive	 men	 and	 women,	 2)	 early	 or	 late	symptomatic	CDC	clinical	disease	 stage	of	 infection,	3)	18	years	of	 age	and	older,	 and	4)	willingness	to	provide	documentation	of	HIV	serostatus	or	consent	to	testing	if	serostatus	was	unknown	or	seronegative.	The	predominance	of	Spanish	as	the	primary	language	was	assessed	 using	 the	 Woodcock-Muñoz	 Language	 Survey-Revised	 to	 evaluate	 Spanish	capacity	(Alvarado,	Ruef,	&	Schrank,	2005)	while	level	of	acculturation	was	assessed	using	a	23-item	acculturation	scale	(Szapocznik,	Scopetta,	Kurtines,	&	Aranalde,	1978)	that	was	part	of	the	HUMANS	battery	(Wilkie	et	al.,	2004).	Parent	 study	 exclusionary	 criteria	 included:	 1)	 the	 presence	 of	 systemic,	 acute	opportunistic	infection	or	tumor	requiring	chemotherapy	at	entry	into	the	study;	2)	severe	HIV-associated	 dementia	 (HAD),	 as	 characterized	 by	 the	 AAN	 1991	 criteria;	 3)	 non-HIV	associated	neurological	diseases	(i.e.,	history	of	epilepsy,	non-correctable	visual	or	hearing	impairments,	 prior	 cerebrovascular	 accident,	 Alzheimer’s	 disease	 at	 entry,	 multi-infarct	
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dementia,	etc.);	4)	current	or	past	history	of	major	psychiatric	disorder,	including,	but	not	limited	 to,	 schizophrenia,	 bipolar	 mood	 disorder,	 and	 major	 depressive	 disorder	 with	melancholia;	mental	retardation,	learning	disorders,	motor	disorders,	behavioral	disorders,	attention	 deficit	 disorder,	 and	 pervasive	 developmental	 disorder;	 5)	 current	 alcohol	 or	substance	dependence,	or	any	history	of	substance	abuse	within	the	three	months	prior	to	assessment	(as	assessed	using	the	standardized	psychiatric	interview	SCID-NP-HIV	with	an	estimated	 cumulative	prevalence	 of	 17%	across	 disorders);	 6)	 collagen	 vascular	 disease;	severe	 chronic	 obstructive	 pulmonary	disease;	 severe	 congestive	 heart	 failure	 (class	 IV);	unstable	 angina;	 myocardial	 infarction;	 7)	 hepatic	 	 or	 renal	 failure;	 8)	 any	 history	 of	treatment	 with	 immunostimulant	 therapies	 and	 other	 trials	 of	 non-FDA	 approved	antiretroviral	 medications;	 and	 	 9)	 residence	 outside	 of	 Los	 Angeles,	 Ventura,	 San	Bernardino,	 and	 Orange	 Counties.	 Individuals	 were	 given	 the	 Cognistat-Version	 Español	(Kiernan,	Mueller,	&	Langston,	1998)	and	the	International	HIV	Dementia	Scale	(Sacktor	et	al.,	2005)	to	screen	for	severe	HAD.	The	current	study’s	exclusionary	criteria	included	all	of	the	above,	in	addition	to	any	individuals	who	did	not	complete	the	associated	functional	or	mood	measures.	
Procedures	Overall	 data	 collected	 included	 HIV	 serology,	 CDC	 clinical	 disease	 stage,	neuropsychological	 (NP)	 test	 variables,	 NP	 outcome	 measures,	 psychosocial	 measures,	functional	measures	 (e.g.,	 cognitive	 complaints),	 categorical	 definitions	 of	 neurocognitive	impairment	 and	disorder,	 qualitative	 indices	 of	 neurocognitive	 impairment,	 and	 relevant	control	 variables	 (i.e.,	 mood	 state,	 acculturation,	 Spanish	 language	 preferred	 usage	 and	ability).	 The	 current	 study	 focused	 primarily	 on	 a	 subset	 of	 this	 data	 relevant	 to	
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neuropsychological	performance,	the	presence	of	neurocognitive	impairment,	self-reported	cognitive	 functioning,	 self-reported	 depressive	 symptoms,	 and	 relevant	 demographic	variables.		 At	 the	 time	 of	 initial	 evaluation	 in	 the	 parent	 study,	 all	 successfully	 pre-screened	participants	were	provided	with	an	 informed	consent	 form	approved	by	the	Cedars-Sinai	Medical	 Center	 IRB.	 Once	 the	 study	 staff	 answered	 all	 of	 the	 participant’s	 questions,	 a	signed	informed	consent	was	obtained	along	with	the	HIV	antibodies	testing	consent	form,	a	 bilateral	medical	 release	 form	 for	 access	 to	 the	 primary	 care	 provider,	 and	 additional	required	HIPAA	 forms.	 Furthermore,	 all	 data	 used	were	 only	 available	 in	 a	 de-identified	manner.			 In	 the	 parent	 study,	 eligible	 participants	 were	 assessed	 via	 a	 comprehensive	neuropsychological	 battery	 as	 well	 as	 a	 psychosocial	 battery.	 The	 neuropsychological	battery	 (NB)	 included	 an	 estimate	 of	 pre-morbid	 intelligence	 and	 assessed	 the	 following	domains:	 attention,	 processing	 speed,	 memory,	 language,	 visuospatial	 functioning,	executive	functioning,	and	fine	and	gross	motor	functioning	(see	Table	1	for	measures	used	in	 each	 domain).	 The	 psychosocial	 battery	 administered	 included	 the	 Beck	 Depression	Inventory	 (BDI;	 Beck,	Ward,	Mendelson	 1961),	 Cognitive	Difficulties	 Scale	 (CDS;	McNair,	Kahn,	Crook,	&	Bartus,	1983),	and	Medical	Outcomes	Study	HIV	Health	Survey	(MOS-HIV;	Wu,	 Revicki,	 Jacobson,	 &	 Malitz,	 1997).	 Participants	 also	 completed	 an	 accompanying	demographic	 questionnaire,	 adherence	 measures,	 a	 substance	 and	 drug	 abuse	 history	questionnaire,	a	smoking	questionnaire,	and	a	questionnaire	of	daily	activities.	Both	 batteries	 were	 administered	 in	 Spanish	 by	 trained	 bilingual	 English	 and	Spanish-speaking	 neuropsychologists	 and	 doctoral	 level	 clinical	 psychology	 students.	
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Testing	was	conducted	over	the	course	of	5-8	hours	and	was	typically	initiated	at	9	AM	in	order	 to	 control	 for	 diurnal	 variation	 in	 participant	 performance.	 Participants	 received	monetary	compensation	for	completing	the	assessment,	as	well	as	a	parking	validation	and	a	meal	voucher	redeemable	at	the	medical	center	cafeteria	on	the	day	of	the	assessment.					
Classification	of	HAND	vs.	No-HAND		 A	 variation	 of	 the	 current	 recommended	 nosology	 for	 HIV-associated	neurocognitive	 disorders	 as	 provided	 by	 the	 AAN	 (Antinori	 et	 al.,	 2007)	 was	 used	 to	distinguish	HAND	status.	As	noted	earlier,	HAND	consists	of	three	distinct	subgroups.	The	first	 is	 ANI,	 which	 in	 this	 study	 will	 be	 characterized	 by	 performances	 between	 1-2	standard	 deviations	 below	 the	 mean	 on	 objective	 tests	 of	 cognitive	 functioning	 in	 the	absence	 of	 reported	 declines	 in	 daily	 functioning.	 Similarly,	 MND	 is	 characterized	 by	performances	 that	 are	 1-2	 standard	 deviations	 below	 the	mean	 in	 the	 presence	 of	mild	reported	declines	in	daily	functioning.	Finally,	HAD	is	characterized	by	performances	that	are	 2	 or	 more	 standard	 deviations	 below	 the	 mean	 with	 marked	 declines	 in	 daily	functioning	reported	in	multiple	domains	(i.e.,	employment,	social	functioning,	medication	management,	 etc.).	 For	 the	 purposes	 of	 this	 study,	 individuals	who	met	 criteria	 for	 ANI,	MND,	 or	 HAD	 were	 categorized	 in	 the	 HAND	 group,	 while	 those	 who	 demonstrated	relatively	intact	performances	(i.e.,	within	+/-	1	SD	of	the	mean)	comprised	the	no-HAND	group.			
Instruments		Instruments	 used	 in	 this	 study	 included	 only	 a	 subset	 of	 the	 larger	 battery	 of	instruments	used	in	the	parent	study.	The	primary	variables	of	focus	for	the	present	study	included	 the	 summary	 of	 NP	 outcome	 measures,	 the	 cognitive	 self-report	 measures,	 a	
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mood	measure,	and	an	acculturation	measure.	The	quantitative	definition	of	the	degree	of	neurocognitive	 impairment	was	 established	 by	 virtue	 of	means	 and	 standard	 deviations	that	are	separately	calculated	on	each	NP	measure	using	appropriately	adjusted	norms.	For	specific	tasks	with	more	than	one	outcome	variable,	all	the	scores	or	measures	within	that	specific	 test	were	 collapsed	and	performance	was	 considered	as	 impaired	 if	 a	 composite	score	of	the	designated	measures	fell	below	a	criterion	value.	The	relevant	values	were	as	follows:	within	 +/-	 1	 SD	 of	 the	 adjusted	mean	was	 designated	 intact;	 1-2	 SDs	 below	 the	adjusted	mean	represented	mild	impairment;	and	2	or	more	SDs	below	the	adjusted	mean	represented	 major	 impairment.	 A	 composite	 score	 was	 used	 in	 an	 effort	 to	 prevent	variance	 on	 the	 number	 of	 impaired	 test	 scores	 generated	 within	 tests	 from	disproportionately	influencing	the	summary	impairment	rating	for	a	given	domain.		For	overall	NP	impairment,	impaired	performances	(i.e.,	one	or	more	SDs	below	the	mean)	 had	 to	 be	 present	 in	 at	 least	 two	 of	 the	 eight	 domains	 assessed	 (i.e.,	attention/concentration,	processing	 speed,	 language,	verbal	memory,	nonverbal	memory,	visuospatial	 functioning,	 executive	 functioning,	 and	motor	 functioning;	 see	Table	 1).	 It	 is	important	to	note	that	each	domain	was	represented	by	two	or	more	measures,	and	as	such	an	 overall	 composite	 score	 for	 that	 domain	 was	 determined.	 A	 list	 of	 all	 the	neuropsychological	measures	 used	 to	 classify	 HAND	 status	 can	 be	 found	 in	 Appendix	 C.	Each	measure	was	compared	to	available	normative	data.		Self-perceived	cognitive	decline	was	assessed	through	the	use	of	Spanish	translated	versions	of	the	Cognitive	Difficulties	Scale	–	Patient	Version	(CDS;	McNair,	Kahn,	Crook,	&	Bartus,	1983),	and	the	Medical	Outcomes	Study	HIV	Health	Survey	(MOS-HIV;	Wu,	Revicki,	Jacobson,	&	Malitz,	1997).	A	Spanish-translated	version	of	the	Beck	Depression	Inventory	
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(BDI;	Beck,	Ward,	Mendelson,	Mock,	&	Erbaugh,	1961)	was	used	to	assess	for	the	presence	of	depressive	 symptoms.	The	Acculturation	Scale	 (ACC;	Szapocznik,	 Scopetta,	Kurtines,	&	Aranalde,	 1978)	 was	 used	 to	 assess	 the	 acculturation	 status	 among	 participants.	 More	information	about	these	measures	is	provided	below.	
Cognitive	Difficulties	Scale-	Patient	Version	(CDS).	The	CDS	(McNair	et	al.,	1983)	is	 a	 39-item	 self-report	 questionnaire	 that	 assesses	 the	 degree	 to	 which	 an	 individual	reports	self-perceived	cognitive	declines	that	impact	everyday	functioning.	Responses	are	made	 using	 a	 Likert	 scale	 of	 0	 to	 4,	 with	 0	 being	 “not	 at	 all,”	 1	 being	 “rarely,”	 2	 being	“sometimes,”	3	being	“often,”	and	4	being	“very	often.”	Aspects	of	cognitive	functioning	that	are	 assessed	 in	 this	 measure	 include	 immediate	 and	 delayed	 memory,	 attention,	psychomotor	 functioning,	 language	 ability,	 and	orientation	 to	 time.	More	 specifically,	 the	items	cover	symptoms	such	as	trouble	recalling	phone	numbers,	needing	to	make	 lists	 to	remember	 things,	 difficulty	with	 orienting	 oneself	 to	 the	 task	 at	 hand,	misplacing	 items,	indecisiveness,	 thinking	 more	 slowly,	 difficulty	 with	 comprehension	 and	 concentration,	distractibility,	 and	 needing	 to	 re-check	 tasks	 performed.	 Higher	 scores	 indicate	 more	impaired	 cognitive	 functioning,	 with	 research	 indicating	 that	 the	 mean	 CDS	 score	 for	 a	general	sample	of	1,628	cognitively	intact,	healthy	adults	aged	45-75	was	45.5	(SD	=	21.4;	Derouesne	 et	 al.,	 1993).	 Factor	 analysis	 has	 suggested	 that	 the	 CDS	 is	 comprised	 of	 the	following	 6	 subscales:	 attention/concentration,	 delayed	 recall/memory,	 prospective	memory,	praxis,	temporal	orientation,	and	orientation	for	persons	(Derouesne	et	al.,	1993).	The	 CDS	 has	 previously	 been	 empirically	 validated	 for	 use	 among	 various	 adult	populations,	 including	 those	 consisting	 of	 healthy	 adults,	 those	 with	 mild	 cognitive	impairment,	 and	 those	 at	 risk	 for	 development	 of	 a	 neurodegenerative	 disease	 (Buelow,	
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Tremont,	 Frakey,	 Grace,	 &	 Ott,	 2014;	 Derouesne	 et	 al.,	 1993).	 A	 study	 by	 Buelow	 and	colleagues	(2014)	found	that	the	CDS	scores	significantly	differed	between	healthy	controls	and	 those	 with	 mild	 cognitive	 impairment;	 however,	 the	 authors	 also	 found	 that	 this	significance	decreased	as	level	of	impairment	increased	(i.e.,	progression	to	dementia).		
Medical	 Outcomes	 Study	 HIV	 Health	 Survey	 (MOS-HIV).	 The	 MOS-HIV	 (Wu,	Revicki,	 Jacobson,	&	Malitz,	 1997)	 is	 a	well-validated,	 4-item,	 self-report	measure	 that	 is	widely	used	 in	HIV	research	and	clinical	 trials	(Revicki,	Chan,	&	Gevirtz,	1998).	The	scale	assesses	the	degree	to	which	an	individual	reports	difficulties	with	the	following	cognitive	tasks	over	the	past	4	weeks:	abstract	reasoning/problem	solving,	memory,	attention,	and	concentration.	Responses	are	made	on	a	Likert	scale	from	1	“All	of	the	time”	to	6,	“None	of	
the	time.	”		Raw	scores	are	converted	to	a	100-point	scale	using	the	following	formula:	(Raw	Score/24)	x	100.	Lower	scores	reflect	worse	cognitive	functioning,	with	research	indicating	that	the	mean	MOS-HIV	score	for	a	sample	of	HIV+	individuals	from	Mexico	was	82.68	(SD	=	18.49;	Peña	de	Leon,	Aguilar	Gaytán,	Suárez	Mendoza,	&	Reyes	Terán,	2007).		The	 MOS-HIV	 has	 been	 shown	 to	 have	 excellent	 internal	 consistency	 and	discriminant	validity	based	on	severity	of	HIV	disease,	performance	based	neurocognitive	function,	 and	 self-reported	 change	 in	 cognitive	 function,	 even	 when	 controlling	 for	depressive	symptoms	(Revicki	et	al.,	1998).	 	Additionally,	 it	has	been	shown	to	be	a	valid	tool	to	assess	HIV-related	functional	declines	among	Spanish-speakers	from	Mexico	(Peña	de	Leon	et	al.,	2007).	
Beck	Depression	Inventory	(BDI)	–	Spanish	Language	Version.	First	developed	in	1961,	the	BDI	(Beck	et	al.,	1961)	is	a	self-report	questionnaire	that	is	frequently	used	for	assessing	 depressive	 symptoms	 in	 Spanish	 speakers	 (Maxson,	 2009,	 2011).	 The	 scale	
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consists	of	21	groups	of	statements,	with	each	group	consisting	of	three	possible	response	choices.	Responses	are	meant	to	reflect	an	individual’s	experience	of	depressive	symptoms	within	the	past	week.	Scores	between	01-10	are	within	normal	limits;	scores	between	11-16	suggest	mild	depressive	symptoms;	scores	between	16	and	23	suggest	the	presence	of	moderate	depressive	symptoms;	and	scores	24	or	greater	indicate	the	presence	of	severe	depressive	symptoms	(Azocar,	Arean,	Miranda,	&	Munoz,	2001).	Although	a	newer	version	of	this	scale	is	available	(BDI-II;	Beck,	Steer,	&	Brown,	1996),	a	Spanish-translated	version	of	the	original	version	of	the	BDI	was	used	in	the	parent	study	and	was	therefore	included	in	the	present	study.	A	study	by	Azocar	and	colleagues	(2001)	using	differential	item	functioning	showed	that	four	of	the	items	on	the	BDI	were	biased	for	Spanish-speakers.	More	specifically,	 the	authors	found	that,	as	compared	to	English-speakers,	Spanish-speaking	Latino	individuals	were	more	 likely	to	endorse	 items	reflecting	tearfulness	and	punishment,	and	 less	 like	to	endorse	 inability	 to	 work.	 Overall,	 the	 authors	 concluded	 that	 the	 BDI	 is	 an	 adequate	measure	for	use	with	Spanish-speaking	individuals,	however,	they	strongly	suggested	that	caution	 is	 needed	when	 interpreting	 the	 results	 due	 to	 demonstrated	bias	 in	 their	 study	(Azocar	et	al.,	2001).	
Acculturation	Scale	 (ACC).	The	Acculturation	Scale	(ACC;	Szapocznik	et	al.,	1978)	is	 a	 23-item,	 self-report	 measure	 that	 assesses	 factors	 such	 as	 context	 and	 patterns	 of	language	 use	 and	 personal	 and	 social	 attitudes	 regarding	 cultural	 identity.	 	 	 The	 first	 7	items	on	the	scale	assess	the	degree	to	which	participants	prefer	to	use	Spanish	or	English	in	 a	 variety	 of	 settings	 (e.g.,	 at	 home,	with	 friends)	 as	well	 as	 use	 of	 and	 preference	 for	English/Spanish	media.	Responses	to	these	items	were	made	on	a	5-point	Likert-type	scale	
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ranging	 from	“Spanish	all	 the	 time”	 to	 “English	all	 the	 time.”	The	next	7	 items	assess	 the	preferences	 in	 cultural	 practices	 such	 as	 dancing	 style,	 music	 choice,	 methods	 of	celebrating,	and	recreational	activities.	Responses	 to	 these	 items	were	also	made	on	a	5-point	Likert-type	scale	ranging	from	“Hispanic	all	of	the	time”	to	“American	all	of	the	time.”		The	 final	 9	 items	 assess	 the	 respondent’s	 desired	 (versus	 actual)	 level	 of	 acculturation	within	various	aspects	of	his	or	her	life	(e.g.,	preference	for	food,	activities,	surroundings,	etc.),	which	were	again	assessed	on	a	5-point	Likert-type	 scale	 ranging	 from	 “I	wish	 this	could	be	completely	Hispanic”	to	“I	wish	this	could	be	completely	American.”	Scores	range	from	a	minimum	of	24	 to	a	maximum	of	120	and	a	midpoint	of	72.	Higher	scores	reflect	greater	 degrees	 of	 acculturation	 and	 English-language	 use	 while	 lower	 scores	 indicate	lower	levels	of	acculturation	(i.e.,	higher	degrees	of	identification	with	native	culture).			
Data	Management		All	data	used	in	this	study	were	stored	on	a	password-protected	computer	that	only	the	researcher	had	access	to.	The	USB	drive	remained	in	a	drawer	in	a	locked	office	in	the	researcher’s	home	when	not	in	use.	All	data	remained	de-identified	and	will	be	retained	for	at	least	three	years	before	being	appropriately	destroyed.		
Data	Analysis		 All	 variables	 were	 plotted	 to	 examine	 the	 distribution	 of	 the	 data	 and	 check	 for	normality.	The	data	were	also	examined	for	outliers	as	determined	by	values	exceeding	1.5	standard	deviations	from	the	mean.	There	were	no	randomly	missing	data,	and	as	such,	a	listwise	deletion	of	incomplete	data	was	not	necessary.			 Descriptive	 statistics	were	 calculated	 on	 all	 four	 primary	measures,	 i.e.,	 the	MOS-HIV,	 CDS,	 BDI,	 and	 ACC.	 Additionally,	 Pearson	 product	 moment	 correlation	 coefficients	
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		 Mean	scores	for	each	of	the	primary	measures	within	the	overall	sample	can	be	seen	in	Table	3.	Scores	on	the	BDI	ranged	from	0-41,	with	a	mean	overall	score	of	12.68	(SD	=	9.81),	 representing	 generally	mild	 depressive	 symptoms	within	 the	 present	 sample	 (N	=	100).	Scores	on	the	CDS	ranged	from	3-144,	with	a	mean	score	of	54.14	(SD	=	30.22).	This	value	 is	 approximately	 10	 points	 higher	 than	 the	mean	 in	 a	 general	 community	 sample	(Durouesne	 et	 al.,	 1993),	 and	 therefore	 suggests	 mildly	 elevated	 cognitive	 complaints.		Scores	 on	 the	MOS-HIV	 ranged	 from	 4-24,	 with	 a	 converted	mean	 score	 of	 69.13	 (SD	 =	19.83)	on	a	100-point	scale,	with	higher	scores	indicating	better	cognitive	functioning.	This	value	is	-0.73	SD	below	the	mean	in	a	sample	of	HIV+	individuals	in	Mexico	(Peña	de	Leon	et	al.,	2007),	suggesting	a	mild	level	of	self-reported	cognitive	decline	or	complaints,	similar	to	 the	 level	obtained	on	the	CDS.	Scores	on	the	acculturation	scale	 for	 the	overall	sample	ranged	from	13-105,	with	a	mean	score	of	46.89	(SD	=	17.80),	which	is	approximately	16	points	 below	 the	 midpoint	 score	 of	 72	 and	 indicative	 of	 generally	 lower	 levels	 of	acculturation	within	this	group.			 As	predicted,	there	was	a	strong	positive	correlation	between	the	BDI	and	the	CDS,	
r(100)	=	0.54,	p	<	0.001.	On	the	CDS	measure,	higher	scores	are	indicative	of	greater	self-reported	 cognitive	 decline.	 Overall,	 increases	 in	 depressive	 symptomatology	 were	significantly	correlated	with	increases	in	cognitive	complaints	on	the	CDS.				 There	was	a	strong	negative	correlation	between	the	BDI	and	the	MOS-HIV,	r(100)	=	-0.53,	p	<	0.001.	This	too	was	consistent	with	the	researcher’s	prediction.	As	noted	earlier,	the	 MOS-HIV	 is	 scored	 such	 that	 lower	 scores	 are	 indicative	 of	 greater	 self-reported	functional	 impairment	 (i.e.,	 more	 cognitive	 complaints).	 Similarly	 to	 the	 CDS,	 this	
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correlation	showed	 that	greater	self-reported	cognitive	complaints	on	 the	MOS-HIV	were	related	to	greater	self-reported	depressive	symptoms.		Table	4	shows	the	intercorrelations	among	the	four	primary	measures	used	in	this	study.	There	was	a	strong	negative	correlation	between	the	CDS	and	the	MOS-HIV,	r(100)	=	-0.63,	 p	 <	 0.001,	 indicating	 that	 increases	 in	 cognitive	 complaints	 on	 the	 CDS	 were	significantly	correlated	with	greater	cognitive	complaints	on	the	MOS-HIV,	as	reflected	by	lower	scores	on	the	MOS-HIV.	This	represented	strong	evidence	of	convergent	validity	for	the	two	measures	used	to	assess	self-reported	cognitive	decline	in	the	study.		Table	4	also	shows	that	 there	was	no	significant	correlation	between	the	ACC	and	any	 of	 the	 other	 three	 primary	 measures	 (i.e.,	 BDI,	 CDS,	 and	 MOS-HIV;	 p’s	 >	 .10).	 This	indicated	that	acculturation	scores	did	not	appear	to	be	significantly	associated	with	scores	on	 the	 other	 measures	 for	 the	 entire	 sample.	 Table	 5	 shows	 the	 means	 and	 standard	deviations	for	the	HAND	and	No	HAND	groups	for	each	of	the	four	primary	measures	in	this	study.	Surprisingly,	the	scores	appeared	quite	similar	across	groups.	This	raised	questions	about	the	actual	meaning	of	the	HAND	vs.	No	HAND	distinction	for	the	present	sample.					 A	2	(HAND	vs.	No	HAND)	x	2	(Complaints	on	MOS-HIV	vs.	No	Complaints	on	MOS-HIV)	ANOVA	was	 conducted	 to	 examine	whether	 the	 presence	 of	 neurocognitive	 decline	interacted	with	self-perceived	cognitive	decline	to	predict	depressive	symptom	scores	from	the	BDI.		Individuals	were	considered	to	have	complaints	when	their	MOS-HIV	scores	were	one	or	more	standard	deviations	below	the	mean.	The	number	of	participants	within	each	group	 was	 as	 follows:	 HAND/Complaints,	 n	 =	 18;	 HAND/No	 Complaints,	 n	 =	 29;	 No	HAND/Complaints,	 n	=	 17;	 No	 HAND/No	 complaints,	 n	=	 36	 (see	 Table	 6	 for	mean	 BDI	scores	for	each	group).	Results	showed	a	main	effect	for	the	MOS-HIV	such	that	those	with	
	 34	
self-perceived	cognitive	decline	reported	greater	depressive	symptoms		(BDI	M	=	18.17,	SD	=	9.53)	than	those	who	did	not	have	cognitive	complaints	(BDI	M	=	9.72,	SD	=	8.67),	F(1,99)	=	20.06,	p	<	.001,		η2p	=	.17.	There	was	no	significant	main	effect	for	HAND,	F(1,	99)	=	.04,	p	=	 .834,	η2p	 =	<	 .0005,	meaning	 that	neurocognitive	 functioning	did	not	have	 a	 significant	impact	on	depressive	symptom	reporting	(HAND:	BDI	M	=	13.09,	SD	=	9.62;	No	HAND:	BDI	
M	=	12.32,	SD	=	10.05).	These	 findings	were	consistent	with	 the	study’s	main	hypothesis	that	 greater	 self-reported	 cognitive	 decline	would	 be	 associated	with	 higher	 BDI	 scores,	regardless	of	HAND	status.			 There	was	a	significant	interaction	between	HAND	and	cognitive	complaints	on	the	MOS-HIV,	F(1,99)	=	4.18,	p	=	.044,	η2p	=	.042	(see	Figure	1).		Follow-up	independent	sample	
t	 tests	 showed	 that	 for	 individuals	 in	 the	 HAND	 condition,	 the	 difference	 in	 BDI	 scores	between	 individuals	with	and	without	cognitive	complaints	was	not	significant	at	 the	 .05	level,	 t(45),	 =	1.60,	p	 =	 .116,	d	=	 .48.	Among	participants	 in	 the	HAND	group,	 those	with	cognitive	 complaints	 had	 a	 mean	 BDI	 score	 of	 15.89	 (SD	 =	 9.	 96),	 which	 was	 not	significantly	 different	 than	 the	 BDI	 mean	 score	 of	 the	 participants	 without	 cognitive	complaints	(M	=	11.34,	SD	=	9.14).	However,	those	in	the	No	HAND	condition	who	reported	cognitive	 complaints	 reported	 significantly	 greater	 depressive	 symptoms	 than	 those	without	cognitive	complaints,	t(51)	=	4.96,	p	<	 .001,	d	=	1.44.	 	Among	participants	within	this	 No	 HAND	 group,	 the	 mean	 BDI	 score	 (M	 =	20.59,	 SD	 =	 8.68)	 for	 those	 individuals	reporting	 cognitive	 complaints	was	 significantly	 greater	 than	 the	mean	 BDI	 score	 of	 the	individuals	who	reported	no	cognitive	complaints	(M	=	8.42,	SD	=	8.17).	A	2	(HAND	vs.	No	HAND)	x	2	(Complaints	on	CDS	vs.	No	Complaints	on	CDS)	ANOVA	was	conducted	to	examine	whether	the	presence	of	neurocognitive	decline	interacted	with	
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self-perceived	 cognitive	 decline	 to	 predict	 depressive	 symptoms.	 Individuals	 with	 CDS	scores	 one	 or	 more	 standard	 deviations	 above	 the	 mean	 were	 regarded	 as	 having	significant	 cognitive	 complaints.	 The	 number	 of	 participants	 within	 each	 group	 was	 as	follows:	HAND/Complaints,	n	=	25;	HAND/No	Complaints,	n	=	22;	No	HAND/Complaints,	n	=	24;	No	HAND/No	complaints,	n	=	29	(see	Table	7	 for	mean	BDI	scores	 for	each	group).	Results	showed	a	main	effect	for	the	CDS,	such	that	those	with	cognitive	complaints	(BDI	M	=	 17.27,	SD	 =	 9.95)	 reported	 greater	depressive	 symptoms	 than	 those	who	did	not	 have	cognitive	complaints	(BDI	M	=	8.27,	SD	=	7.42),	F(1,	99)	=	25.27,	p	<	.001,	η2p	=	.208.	There	was	no	significant	main	effect	for	HAND,	F(1,99)	=	.000,		p	=.983,	η2p	=	.000.	Once	again,	this	was	 consistent	 with	 the	 study’s	 main	 hypothesis	 in	 that	 greater	 self-reported	 cognitive	complaints	on	the	CDS	were	associated	with	higher	BDI	scores	regardless	of	HAND	status.		There	was	no	significant	interaction	between	HAND	and	cognitive	complaints	on	the	CDS,	F(1,99)	=	.697,	p	=	.406,	η2p	=	.007.		In	addition,	an	examination	of	acculturation	as	a	covariate	revealed	that	acculturation	level	did	not	impact	the	relationship	of	HAND	status	and	cognitive	complaints	to	depressive	symptom	scores	from	the	BDI	(p’s	>	.10).	Moreover,	this	was	true	for	analyses	with	both	the	CDS	and	the	MOS-HIV.			
Discussion		 In	the	present	study,	the	relationship	between	self-perceived	cognitive	decline	and	neuropsychological	 functioning	on	depressive	symptoms	was	examined.	As	hypothesized,	higher	 levels	 of	 self-perceived	 cognitive	 decline	 (i.e.,	 more	 cognitive	 complaints)	 were	associated	 with	 higher	 levels	 of	 depressive	 symptoms	 regardless	 of	 the	 presence	 of	objective	cognitive	decline	(i.e.,	HAND	vs.	No-HAND	status).			These	findings	are	consistent	with	 extant	 literature	 that	 shows	 that	 endorsement	 of	 higher	 levels	 of	 depressive	
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symptoms	is	correlated	with	greater	cognitive	complaints	among	HIV+	individuals	(Carter	et	al.,	2003;	Cysique	et	al.,	2007;	Hinkin,	Castellon,	Van	Gorp,	&	Satz,	1998;	Rourke	et	al.,	1999;	Sadek	et	al.,	2007;	Thames	et	al.,	2011).	 	 In	these	studies,	the	discrepancy	between	cognitive	 complaints	 and	 objective	 neuropsychological	 performance	 is	 labeled	 over-reporting	of	cognitive	decline,	as	the	level	of	self-perceived	cognitive	decline	was	found	to	be	greater	than	objectively	measured	on	neuropsychological	testing.		In	 addition,	 there	 was	 an	 interaction	 between	 self-perceived	 cognitive	 decline,	 as	measured	by	the	MOS-HIV,	and	neurocognitive	functioning	on	depressive	symptoms.	 	For	those	individuals	without	objectively	determined	neurocognitive	decline	(i.e.,	the	No-HAND	group),	 those	 who	 reported	 cognitive	 complaints	 endorsed	 greater	 symptoms	 of	depression	compared	to	those	with	no	cognitive	complaints.	This	was	consistent	with	the	correlational	 findings	for	the	entire	sample:	greater	cognitive	complaints	were	associated	with	greater	depressive	symptoms.		However,	 among	 those	 in	 the	 HAND	 group	 (n	 =	 47),	 the	 difference	 in	 BDI	 scores	between	those	with	cognitive	complaints	on	the	MOS-HIV	(n	=	29)	and	those	without	(n	=	18)	 did	 not	 reach	 the	 .05	 level	 of	 statistical	 significance.	 The	 difference	 in	 BDI	 scores	between	 these	 two	 subgroups	 was	 in	 the	 expected	 direction,	 i.e.,	 those	 with	 cognitive	complaints	 obtained	 a	 higher	 BDI	 mean	 score	 (15.89)	 than	 those	 without	 cognitive	complaints	 (11.34).	However,	 this	 difference	 in	BDI	 scores	between	 subgroups	 appeared	smaller	 than	 the	difference	 in	BDI	 scores	between	 subgroups	 in	 the	No	HAND	condition.	This	 finding	 raises	 questions	 about	 whether	 the	 relationship	 between	 self-reported	cognitive	decline	and	depressive	symptoms	may	differ	as	a	 function	of	HAND	status.	This	finding	needs	to	be	replicated	and	was	based	on	a	relatively	small	number	of	participants.	
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However,	 if	 replicated	 in	 larger	samples	 this	 finding	could	be	relevant	 to	clinical	practice	because	it	might	highlight	the	need	for	clinicians	to	be	aware	of	HAND	status	among	HIV+	Spanish	speakers	when	considering	the	meaning	of	self-reported	cognitive	complaints	and	depressive	symptoms.		One	 interesting	 and	 somewhat	 surprising	 finding	 was	 there	 were	 not	 greater	differences	between	the	HAND	and	No	HAND	groups	in	their	mean	scores	on	the	CDS,	the	MOS-HIV,	and	the	BDI.		Indeed,	comparison	of	the	mean	scores	across	these	three	measures	revealed	minimal	differences	between	groups,	which	raised	questions	about	 the	practical	meaning	 of	 the	 HAND	 vs.	 No	 HAND	 distinction	 in	 this	 sample.	 In	 absolute	 terms,	 the	greatest	difference	between	groups	appeared	to	be	on	the	acculturation	measure,	with	the	HAND	group	obtaining	the	lower	mean	score.	Clearly,	more	research	with	larger	samples	is	needed	to	determine	the	extent	to	which	the	present	findings	will	be	replicated.		The	relationship	of	self-reported	cognitive	complaints	to	depressive	symptoms	in	HIV+	individuals	who	are	Spanish	speaking	needs	more	attention.	It	is	important	to	consider	the	literature	 examining	 self-report	 of	 symptoms.	 For	 example,	 there	 is	 evidence	 to	 suggest	that	 individuals	 who	 exhibit	 trait	 negative	 affect	 also	 tend	 to	 be	 hypervigilant	 about	monitoring	 themselves	 and	 have	 a	 lower	 threshold	 for	 noticing	 and	 reporting	 subtle	changes	(Pennebaker,	2000).	While	it	may	be	tempting	based	on	the	literature	to	attribute	self-reported	 cognitive	 decline	 in	 the	 absence	 of	 objectively	 determined	neuropsychological	impairment	to	over-reporting,	there	may	be	other	considerations.	For	example,	 those	who	report	cognitive	complaints	 in	the	absence	of	objectively	determined	cognitive	 decline	 may	 perceive	 cognitive	 changes	 that	 are	 subtle	 or	 that	 are	 not	 being	detected	 through	 conventional	 assessment.	 If	 such	 individuals’	 cognitive	 complaints	 are	
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minimized,	they	may	feel	 invalidated,	which	may	lead	to	lack	of	engagement	in	treatment	and	 perhaps	 increased	 feelings	 of	 helplessness	 and	 depressive	 symptoms.	 Clearly	 more	research	is	needed.				Given	 that	 self-report	 can	 be	 influenced	 by	 factors	 such	 as	 culture,	 this	 study	explored	 the	role	of	acculturation	 in	 the	relationship	between	objective	cognitive	decline	and	 neuropsychological	 functioning	 on	 depressive	 symptoms.	 Ultimately,	 the	 present	analyses	 failed	 to	 support	 acculturation	 as	 a	 covariate	 in	 this	 relationship.	 Acculturation	scores	did	not	appear	to	be	significantly	associated	with	the	three	primary	measures	used	in	 the	 present	 study.	 This	 is	 inconsistent	 with	 findings	 that	 acculturation	 status	 is	correlated	with	depression	among	Latinos	(Gonzales	et	al.,	2009;	Rivera,	2007)	though	this	literature	 is	 equivocal	 and	 has	 been	 shown	 to	 be	 moderated	 by	 factors	 such	 as	socioeconomic	 status	 (Cuéllar	 &	 Roberts,	 1995)	 and	 intercultural	 competence	 (Torres	&	Rollock,	 2007).	 	 It	 should	 be	 noted	 that	 overall,	 BDI	 scores	 were	 relatively	 low	 for	 the	present	 sample,	 as	 was	 overall	 level	 of	 acculturation,	 particularly	 for	 the	 HAND	 group.	Another	 important	 factor	 to	note	 is	 that	 the	measure	used	 in	 the	present	 study,	 the	ACC	(Szapocznik	et	al.,	1978),	was	developed	based	on	more	traditional	models	of	acculturation	while	more	modern	models	 of	 acculturation	 are	 assessed	 in	 a	multidimensional	manner	(see	 Schwartz,	Unger,	 Zamboanga,	&	 Szapocznik,	 2010).	As	 such,	 future	 research	using	 a	multidimensional	 measure	 of	 acculturation	 among	 a	 sample	 with	 greater	 degrees	 of	acculturation	may	better	serve	to	evaluate	its	 influence	on	self-reported	cognitive	decline	and	 depressive	 symptoms.	 Overall,	 findings	 in	 the	 current	 study	 suggest	 that	 the	 role	played	by	acculturation	on	 these	 factors	 is	not	yet	well	understood	and	warrants	 further	exploration.		
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Limitations		An	important	limitation	of	any	archival	study	is	that	the	researcher	must	accept	the	data	 as	 they	 have	 been	 collected,	 without	 the	 possibility	 of	 introducing	 any	 changes	 in	procedure	or	any	additional	measures.	The	design	of	the	present	study	did	not	permit	the	researcher	to	identify	any	causal	relationships,	given	that	a	true	experimental	design	was	not	 employed.	 	 Additionally,	 the	 lack	 of	 a	 control	 group	 (i.e.,	 HIV-negative	 Spanish-speakers)	with	which	to	compare	means	was	an	important	limitation	of	the	study.	With	the	exception	 of	 the	 objective	 neuropsychological	 tests,	much	 of	 the	 data	 obtained	 relied	 on	self-report.	As	previously	discussed,	there	are	a	number	of	limitations	associated	with	the	use	of	self-report	measures,	including	the	possibility	of	over-	or	under-reporting	symptoms	and	 impairment.	As	such,	an	 ideal	assessment	of	both	mood	and	 functional	ability	would	have	 involved	 multiple	 methods	 (e.g.,	 collateral	 informant	 ratings,	 clinician	 ratings,	objective	tests	of	functioning,	etc.)	rather	than	being	limited	to	self-report.	One	 limitation	 of	 the	 guidelines	 used	 for	 establishing	 neuropsychological	impairment	 in	 studies	 such	 as	 the	 present	 one	 is	 the	 relative	 non-equivalence	 of	 the	number	of	 tests	utilized	across	domains.	As	a	 result,	 one	domain	may	be	 represented	by	more	than	two	tests,	while	another	domain	is	represented	by	only	two	tests.	To	ensure	that	each	 domain’s	 contribution	 to	 overall	 impairment	 is	 relatively	 equivalent,	 a	 composite	score	 was	 used	 in	 each	 domain	 where	 more	 than	 one	 measure	 was	 used	 to	 assess	functioning.		Another	limitation	of	the	present	study	had	to	do	with	the	criteria	for	participation	in	the	parent	study.	Persons	with	histories	of	severe	mood	disorders	tended	to	be	excluded	from	participation.	As	a	result,	this	no	doubt	limited	the	variance	in	BDI	scores.		
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In	 regard	 to	 identifying	 participants	 who	 reported	 cognitive	 complaints	 vs.	 those	who	did	not,	composition	of	the	subgroups	varied	depending	upon	whether	the	CDS	or	the	MOS-HIV	was	used.	While	the	CDS	and	MOS-HIV	showed	good	convergent	validity,	the	fact	that	the	subgroups	differed	as	a	function	of	the	self-report	measure	used	was	an	additional	limitation	of	the	study.				Other	limitations	included	the	fact	that	the	sample	of	Spanish-speakers	assessed	in	this	study	consisted	entirely	of	individuals	living	in	the	greater	Los	Angeles	area	and	is	not	therefore	 fully	 representative	 of	 HIV-positive	 Spanish-speakers	 living	 in	 other	 parts	 of	California	or	in	other	states.	There	may	also	have	been	uncontrolled	factors	impacting	the	self-selection	 process	 for	 participation	 in	 the	 original	 study	 that	 could	 affect	 the	generalizability	of	the	results.	For	example,	it	could	be	that	individuals	who	were	motivated	to	 participate	 in	 the	 original	 study	were	 either	 doing	 exceptionally	well	 or	 exceptionally	poorly	in	their	functioning.		With	 regard	 to	 sample	 characteristics,	 an	 important	 limitation	 to	 note	 is	 the	overrepresentation	 of	 men	 as	 compared	 to	 women	 and	 transgender	 individuals.	Furthermore,	the	inclusion	of	transgender	individuals	provides	an	interesting	challenge	in	that	 supplementary	 information	 that	 could	 impact	 performance	 outcome	 was	 not	 fully	assessed	 (i.e.,	 age	 of	 transition,	 history	 of	 hormone	 replacement	 therapy,	 etc.).	Furthermore,	 the	 overall	 acculturation	 level	within	 the	 sample	was	 generally	 low,	which	may	 also	 have	 limited	 the	 generalizability	 of	 the	 findings.	 	 	 Indeed,	 exploration	 of	 the	impact	of	cognition,	acculturation,	and	mood	 in	 this	particular	subset	of	 the	HIV-positive,	Spanish-speaking	community	is	sorely	lacking.	
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Neuropsychological	Battery		Cognitive	Domain	 Measure	 Author	Attention/Concentration	 Digit	Span		Spatial	Span	Continuous	Performance	Test	II	(CPT-II)	
Wechsler,	1987,	1997;	Conners	&	Staff,	2000	




Language	 Boston	Naming	Test	California	Oral	Word	Association	Test	 Kaplan,	Goodglass,	&	Weintraub,	1983;	Benton	&	Hamser,	1976	Visuospatial	Functioning	 WAIS-III							Block	Design							Matrices	 Wechlser,	1997	Executive	Functioning	 Color	Trails	Color	Figure	Mazes	Wisconsin	Card	Sorting	Test	(WCST)	Stroop	Test	(Golden	Version)	
D’Elia,	Satz,	Uchiyama,	&	White,	1994;	Maj	et	al.,	1994;	Heaton,	1981;	Golden,	1978	





Variable	 HAND	(n	=	53)	 No-HAND	(n	=	47)	Age	Mean(SD)	 45.21	(1.12)	 44.72	(1.05)	Education	 10.81	(0.58)	 9.74	(0.36)	Gender	 	 											%	Male	 55.2%	 52.4%											%	Female	 37.9%	 19.0%											%	Transgender		 6.9%	 14.3%	
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Table	3			






















Mean	BDI	Scores	by	HAND	status	and	Presence	of	Complaints	on	CDS		Measure	 +	HAND	+	Complaints	 +	HAND	-	Complaints	 -	HAND	+	Complaints	 -	HAND	-Complaints	
BDI	 16.56(8.96)	

























































































































































































































































































































































































































































































































































Graduate & Professional Schools Institutional Review Board 
6100 Center Drive, Los Angeles, California 90045      310-568-5600 
August 21, 2015 
Ahoo Karimian 
Protocol #: P0715D03 
Project Title: Self-Perceived Cognitive Decline, Depressive Symptoms, and Neuropsychological 
Functioning among HIV+ Spanish Speakers    
Dear Ms. Karimian: 
Thank you for submitting your application, Self-Perceived Cognitive Decline, Depressive Symptoms, and 
Neuropsychological Functioning among HIV+ Spanish Speakers, for exempt review to Pepperdine 
University’s Graduate and Professional Schools Institutional Review Board (GPS IRB).  The IRB 
appreciates the work you and your faculty advisor, Dr. Mitchell, have done on the proposal.  The IRB has 
reviewed your submitted IRB application and all ancillary materials.  Upon review, the IRB has determined 
that the above entitled project meets the requirements for exemption under the federal regulations (45 
CFR 46 - http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html) that govern the protections of 
human subjects. Specifically, section 45 CFR 46.101(b)(2) states: 
(b) Unless otherwise required by Department or Agency heads, research activities in which the only 
involvement of human subjects will be in one or more of the following categories are exempt from 
this policy: 
Category (2) of 45 CFR 46.101, research involving the use of educational tests (cognitive, 
diagnostic, aptitude, achievement), survey procedures, interview procedures or observation of public 
behavior, unless: a) Information obtained is recorded in such a manner that human subjects can be 
identified, directly or through identifiers linked to the subjects; and b) any disclosure of the human 
subjects' responses outside the research could reasonably place the subjects at risk of criminal or 
civil liability or be damaging to the subjects' financial standing, employability, or reputation. 
Your research must be conducted according to the proposal that was submitted to the IRB.  If changes to 
the approved protocol occur, a revised protocol must be reviewed and approved by the IRB before 
implementation.  For any proposed changes in your research protocol, please submit a Request for 
Modification Form to the GPS IRB.  Because your study falls under exemption, there is no requirement 
for continuing IRB review of your project.  Please be aware that changes to your protocol may prevent the 
research from qualifying for exemption from 45 CFR 46.101 and require submission of a new IRB 
application or other materials to the GPS IRB.   
A goal of the IRB is to prevent negative occurrences during any research study.  However, despite our 
best intent, unforeseen circumstances or events may arise during the research.  If an unexpected situation 
or adverse event happens during your investigation, please notify the GPS IRB as soon as possible.  We 
will ask for a complete explanation of the event and your response.  Other actions also may be required 
depending on the nature of the event.  Details regarding the timeframe in which adverse events must be 
reported to the GPS IRB and the appropriate form to be used to report this information can be found in the 
Pepperdine University Protection of Human Participants in Research: Policies and Procedures Manual 
(see link to “policy material” at http://www.pepperdine.edu/irb/graduate/). 
Please refer to the protocol number denoted above in all further communication or correspondence related 
to this approval.  Should you have additional questions, please contact Kevin Collins, Manager of the 
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Institutional Review Board (IRB) at gpsirb@peppderdine.edu.  On behalf of the GPS IRB, I wish you 
success in this scholarly pursuit. 
Sincerely, 
Thema Bryant-Davis, Ph.D. 
Chair, Graduate and Professional Schools IRB 
cc:  Dr. Lee Kats, Vice Provost for Research and Strategic Initiatives 
Mr. Brett Leach, Regulatory Affairs Specialist 






Domain	Assessed	 Assessment	Measure	Premorbid	Intellectual	Functioning	 WAIS-III	Vocabulary	Test	Attention/Concentration	 WAIS-III	Digit	Span,	Spatial	Span;	Continuous	Performance	Test	II	(CPT-II)	Information	Processing	Speed	 WAIS-III	Symbol	Search,	Digit	Symbol;	CPT-II	Language	 Boston	Naming	Test;	Controlled	Oral	Word	Association	Test	(COWAT,	PMR);	Category	Fluency	(Animals)	Visuospatial	Functioning	 WAIS-III	Block	Design,	Matrices	Executive	Functioning	 Color	Trails	2;	Wisconsin	Card	Sorting	Test	(WCST);	Stroop	Test	(Golden	Version)	Motor	Functioning	 Grooved	Pegboard;	Finger	Tapping;	Timed	Gait	Memory	 Rey	Auditory	Verbal	Learning	Test	(RAVLT);	WMS-IV	Logical	Memory	I	&	II,	Visual	Reproduction;	Picture	Memory	Interference	Test-3				
